Innova Captab Limited (NSE:INNOVACAP)

India flag India · Delayed Price · Currency is INR
728.40
+8.10 (1.12%)
Apr 29, 2026, 3:29 PM IST
-17.87%
Market Cap 41.68B
Revenue (ttm) 14.97B
Net Income (ttm) 1.32B
Shares Out 57.22M
EPS (ttm) 23.13
PE Ratio 31.49
Forward PE 23.62
Dividend 4.00 (0.56%)
Ex-Dividend Date Jan 30, 2026
Volume 44,904
Average Volume 68,153
Open 724.35
Previous Close 720.30
Day's Range 723.00 - 739.00
52-Week Range 622.00 - 1,020.70
Beta -0.33
RSI 57.20
Earnings Date May 21, 2026

About Innova Captab

Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also offers various generic formulation products, including cephalosporins, proton pump inhibitor, anticholinergic and heparin NSAIDs, analgesics and antipyretic, anticold and antiallergic, antiemetic, antidiabetic, antispasmodic, antifibrinoly... [Read more]

Sector Healthcare
Founded 2005
Employees 1,600
Stock Exchange National Stock Exchange of India
Ticker Symbol INNOVACAP
Full Company Profile

Financial Performance

In fiscal year 2025, Innova Captab's revenue was 12.44 billion, an increase of 15.02% compared to the previous year's 10.81 billion. Earnings were 1.28 billion, an increase of 35.95%.

Financial Statements

News

There is no news available yet.